Design and Validation of Multiplexed Respiratory RT-LAMP assay for the differentiation of SARS-CoV-2, Influenza A and Respiratory Syncytial Virus (RSV) in COVID-19 Pandemic Samples from Western Kenya.

The COVID-19 pandemic highlighted the importance of widespread, accessible viral surveillance to ensure pandemic-preparedness. The rapid diagnosis of respiratory infections is crucial not only for effective patient management but also to inform ongoing surveillance for the detection of outbreaks. Reverse transcriptase-Loop mediated isothermal amplification (RT-LAMP) assays are an attractive alternative to reverse transcriptase polymerase chain reaction (RT-PCR) for rapid, decentralised testing in resource limited settings due being rapid and low cost. Here we present the design and evaluation

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.